ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO142

Effect of Dialysate Bicarbonate on Calciprotein Crystallization Time (T50) in Hemodialysis Patients: The D-Bic Study

Session Information

  • CKD-MBD: Clinical
    October 24, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Bone and Mineral Metabolism

  • 502 Bone and Mineral Metabolism: Clinical

Authors

  • Cejka, Daniel, Ordensklinikum Linz GmbH Elisabethinen, Linz, Oberösterreich, Austria
  • Neufeld, Peter Stefan, Ordensklinikum Linz GmbH Elisabethinen, Linz, Oberösterreich, Austria
  • Pasch, Andreas, Calciscon AG, Biel, Switzerland
  • Smith, Edward R., Royal Melbourne Hospital, Parkville, Department of Nephrology Victoria, Australia, Melbourne, Victoria, Australia
  • Gaggl, Martina M., Center for Public Health, Public Health Nutrition, Medical University Vienna, Vienna, Austria
  • Haller, Maria C., Ordensklinikum Linz GmbH Elisabethinen, Linz, Oberösterreich, Austria
  • Machacek, Jennifer Daniela, Ordensklinikum Linz GmbH Elisabethinen, Linz, Oberösterreich, Austria
Background

Short calciprotein crystallization time (low T50) is directly associated with increased risk of cardiovascular events and mortality. Higher serum bicarbonate levels consistently correlate with higher T50 time in observational studies. However, oral supplementation of sodium bicarbonate failed to increase T50 times in interventional studies in CKD patients. Here, we investigated whether increases in dialysate bicarbonate concentrations increase T50 times.

Methods

In a prospective, single center, single arm, interventional trial, dialysate bicarbonate was decreased from baseline settings to 27 mmol/l (D-Bic 27) in a step-wise fashion (2 mmol/l change per dialysis session), followed by a step-wise increase in dialysate bicarbonate settings to 37 mmol/l (D-Bic 37), over a course of 6 weeks. The primary endpoint was the change in T50 time between the D-Bic 27 and D-Bic 37 phase.

Results

Of 29 recruited patients, 24 completed the study per protocol. T50 time increased significantly from 246 ± 77 to 282 ± 81 minutes from the D-Bic 27 to the D-Bic 37 phase (p<0.0001). The hydrodynamic radius (size) of secondary calciprotein particles generated in the T50 test (CPP-2Rh) did not differ significantly between the D-Bic 27 and D-Bic 37 phase (251± 75 vs. 240 ± 78 nm, p=0.27). Serum bicarbonate, serum pH, and intact parathyroid hormone (PTH) increased significantly, while ionized serum calcium decreased significantly from the D-Bic 27 to the D-Bic 37 phase. Serum potassium, phosphate and magnesium did not change significantly throughout the study.

Conclusion

Increases in dialysate bicarbonate led to significant increases in T50 time.